Changes in bone turnover markers and menstrual function after short- term oral DHEA in young women with anorexia nervosa

Journal of Bone and Mineral Research

Volumn 14, Issue 1, 1999, Pages 136-145

  Gordon, Catherine M ^a,b   Grace, Estherann ^a   Emans, S Jean ^a   Goodman, Elizabeth ^a   Crawford, Margaret H ^a   Leboff, Meryl S ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ESTRADIOL; OSTEOCALCIN; PRASTERONE; SOMATOMEDIN C; TESTOSTERONE;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HORMONAL THERAPY; HUMAN; MENSTRUAL CYCLE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; ANDROGENS; ANOREXIA NERVOSA; BIOLOGICAL MARKERS; BONE REMODELING; DEHYDROEPIANDROSTERONE; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MENSTRUAL CYCLE; OSTEOCALCIN;

EID: 0032919545     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.1.136     Document Type: Article

References (53)

1. Rigotti N, Neer R, Skates S, Herzog DB, Nussbaum SR 1991 The clinical course of osteoporosis in anorexia nervosa. JAMA 265:1133-1138.
2. Lloyd T, Andor MB, Rollings N, Martel JK, Landis JR, Demers LM, Eggli DF. Kieselhorst K. Kulin HE 1993 Calcium supplementation and hone mineral density in adolescent girls. JAMA 270:841-844.
3. Rutherford OM 1993 Spine and total body bone mineral density in amenorrheic athletes. Appl Physiol 74:2904-2908.
4. Walsh BT, Roose SP, Katz JL, Dyrenfurth I, Wright L, Vande Wiele R, Glassman AH 1987 Hypothalamic-pituitary-adrenocortical activity in anorexia nervosa and bulimia. Psychoneuroendocrinology 12:131-140.
5. Biller MK, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A 1989 Mechanism of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 68:548-554.
6. Zumoff B, Walsh BT, Katz JL, Levin J, Rosenfeld RS, Kream J, Weiner H 1983 Subnormal plasma dehydroepiandrosterone to cortisol ratio in anorexia nervosa: A second hormonal parameter of onlogenic regression. J Clin Endocrinol Metab 56:668-671.
7. Devesa J, Perez-Fernandez R. Bokser L, Gaudeiero GJ. Lima L, Casanueva FF 1987 Adrenal androgen secretion and dopaminergic activity in anorexia nervosa. Horm Metab Res 20:57-60.
8. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D. Klibanski A 1996 Effects of short-term recombinant human insulin-like growth factor administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 81:3864-3870.
9. Ott S 1991 Bone density in adolescents. N Engl J Med 325:1646-1647.
10. Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R 1990 Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 86:440-447.
11. Zumoff B, Rosen fel RS, Strain GW, Levin J, Fukushima DK 1980 Sex differences in the 24-hour mean plasma concentrations of dehydroisoiandrosterone (DHA) and dehydroisoandorsterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 51:330-333.
12. Mortola JF, Yen SSC 1990 The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 71:696-704.
13. Orentreich N, Brind JL, Rizer RL, Vogelman JH 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout childhood. J Clin Endocrinol Metab 59:551-555.
14. Casson PR, Straughn AB, Umstot ES, Abraham GE, Carson SA, Buster JE 1996 Delivery of dehydroepiandrosterone to premenopausal women: Effects of micronization and administration. Am J Obstet Gynecol 174:649-653.
15. Taelman P, Kaufman JM, Janssens X, Vermeulen A 1989 Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late post-menopause. Maturitas 11:65-73.
16. Steinberg KK, Freni-Titulaer LW, DePuey EG, Miller DT, Sgoutas DS, Coralli CH, Phillips DL, Rogers TN, Clark RV 1989 Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 69:533-539.
17. Kriepe RE, Hicks DG, Rosier RN, Puras JE 1993 Preliminary findings on the effects of sex hormones on bone metabolism in anorexia nervosa. J Adolesc Health 14:319-324.
18. Klibanski A, Biller BMK, Schoenfeld DA, Herzog DB, Saxe V 1995 The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80:898-904.
19. Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukri K, Smith J 1996 Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 81:37-43.
20. Rockett H, Wolf A, Colditz G 1995 Development and reproducibility of a food frequency questionnaire to assess diets of older children and adolescents. J Am Diet Assoc 95:336-339.
21. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J 1961 An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
22. Piazza E, Rollins N, Lewis FS 1983 Measuring severity and change in anorexia nervosa. Adolescence 70:293-305.
23. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE 1982 The eating attitudes test: Psychometric features and clinical correlates. Psychol Med 12:871-878.
24. Spielberger CD, Gorsuch RL, Lushene R, .Vagg PR, Jacobs GA 1983 Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press. Palo Alto, CA, U.S.A.
25. National Center for Health Statistics: Height and Weigh of Youth United States 1973 Vital Health Statistics, Vol 11(124). Health Services and Mental Health Administration, U.S. Government Printing Office, Washington, DC, U.S.A.
26. El-Hajj Fuleihan G, Testa MS, Angell JE, Porrino N, LeBoff MS 1995 Reproducibility of DXA absorptiometry: A model for bone loss estimates. J Bone Miner Res 10:1004-1014.
27. Tobiume H, Kanzaki S, Hida S, Ono T, Moriwake T, Yamauchi S, Tanaka H, Seino Y 1997 Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone deficiency: A potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab 82:2056-2061.
28. Jacobs S, Hilliard TC 1996 Hormone replacement therapy in the aged: A state of the art review. Drugs Aging 8:193-213.
29. Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A 1989 Osteopenia in men with a history of delayed puberty. N Engl J Med 326:600-604.
30. Munoz-Torres M, Jodar E, Quesada M, Escobar-Jiminez F 1995 Bone mass in androgen-insensitivity syndrome: Response to hormonal replacement therapy. Calcif Tissue Int 57:94-96.
31. Frisch RE, McArthur JW 1974 Menstrual cycles: fatness as a determinant of minimum weight necessary for the maintenance or onset. Science 185:949-951.
32. Frisch RE, Canick JA, Tulchinsky D 1980 Human fatty marrow aromatizes androgens to estrogens. J Clin Endocrinol Metab 51:367-372.
33. Martel C, Sourla A, Pelletier G, Labrie C, Fournier M, Picard S, Li S, Stojanovic M, Labrie F 1998 Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat. J Endocrinol 157:433-442.
34. Labrie F 1991 Intracrinology. Mol Cell Endocrinol 78:C113-C118.
35. Kasperk CH, Wakley GK, Hierl T, Ziegler R 1997 Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J Bone Miner Res 12:464-471.
36. Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B 1997 Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women. J Clin Endocrinol Metab 82:3498-3505.
37. Boot AM, de Ridder MAJ, Pols HAP, Krenning EP, de Muinck Keizer-Schrama SM 1997 Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab 82:57-62.
38. Horowitz MC 1993 Cytokines and estrogen in bone: Antiosteoporotic effects. Science 260:626-627.
39. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC 1992 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891.
40. Labrie F, Belanger A, Cusan L, Gomez J, Candas B 1997 Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 82:2396-2402.
41. Rosen CJ, Donahue LR, Hunter SJ 1994 Insulin-like growth factors and bone: The osteoporosis connection. Proc Soc Exp Biol Med 206:83-102.
42. Canalis E, McCarthy T, Centrella M 1989 The role of growth factors in skeletal remodeling. Endocrinol Metab Clin North Am 18:903-918.
43. Counts DR, Gwirtsman H, Carlsson LMS, Lesem M, Cutler GB 1992 The effect of anorexia nervosa and refeeding on growth hormone binding protein, the insulin-like growth factors (Igs) and the IGF-binding proteins. J Clin Endocrinol Metab 75:762-767.
44. McCarthy TL, Centrella M, Canalis E 1989 Regulatory effects of insulin-like growth factors-I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 124:301-309.
45. Canalis E, Lian JB 1988 Effects of bone-associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 9:243-246.
46. Morales AJ, Nolan JJ, Nelson JC, Yen SSC 1994 Effects of replacement dose dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78:1360-1367.
47. Gray TK, Mohan S, Linnkhart TA, Williams ME, Baylink DJ 1988 Estrogen may mediate its effects on bone cells by signaling the observation of growth factors. J Bone Miner Res 3:A552.
48. 1. Calcif Tissue Res 42:117 (abstract).
49. Diamond P. Cusan L, Gomez JL, Belanger A, Lahrie F 1996 Metabolic effects of 12-month DHEA replacement therapy in postmenopausal women. J Endocrinol 150:S43-S50.
50. Trussell J 1980 Statistical flaws in evidence for the Frisch hypothesis that fatness triggers menarche. Hum Biol 52:711-720.
51. Golden NH, Jacobson MS, Schebendach J, Solanto MV, Hertz SMR 1997 Resumption of menses in anorexia nervosa. Arch Adolesc Pediatr Med 151:16-21.
52. Silber TJ 1997 Resumption of menses in anorexia: New research findings and their clinical implications. Arch Pediatr Adolesc Med 151:14-15.
53. Delmas PD 1993 Biochemical markers of bone turnover. J Bone Miner Res 8:549-556.